Viral arthritis

Current Opinion in Rheumatology

Volumn 8, Issue 4, 1996, Pages 341-345

  Schnitzer, Thomas J ^a   Penmetcha, Mohan ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC FATIGUE SYNDROME; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INFECTIOUS ARTHRITIS; JUVENILE RHEUMATOID ARTHRITIS; PARVOVIRUS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0029757426     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199607000-00011     Document Type: Review

References (17)

1. Gross K, Combe C, Krüger K, Schattenkirchner M: Arthritis after hepatitis B vaccination. Scand J Rheumatol 1995, 24:50-52.
2. Gross JB Jr, Persing DH: Hepatitis C: advances in diagnosis. Mayo Clin Proc 1995, 70:296-297. This article describes various assays available for HCV RNA including the newer technique of genotyping. These quantitative and semiquantitative assays may be useful in monitoring response to interferon treatment.
3. Pawlotsky J-M, Roudot-Thoraval F, Simmonds P, Mellor J, Yahia MB, André C, Voisin MC, Intrator L, Zafrani ES, Duval J, Dhumeaux D: Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995, 122:169-173. The authors studied 59 consecutive patients with chronic HCV infection for extrahepatic immunogenic manifestations. The prevalence of these abnormalities was found to be high and did not differ significantly among patients infected with different serotypes.
4. Marchesoni A, Battafarano N, Podico M, Tosi S: Hepatitis C virus antibodies and systemic lupus erythematosus [letter]. Clin Exp Rheumatol 1995, 13:267-273.
5. Nesher G, Osborn TG, Moore TL: Parvovirus infection mimicking systemic lupus erythematosus. Semin Arthritis Rheum 1995, 24:297-303.
6. Gran JT, Johnsen V, Myklebust G, Nordbø SA: The variable clinical picture of arthritis induced by human parvovirus B19. Scand J Rheumatol 1995, 24:174-179.
7. Cassinotti P, Bas S, Siegl G, Vischer TL: Association between human parvovirus B19 infection and arthritis. Ann Rheum Dis 1995, 54:498-500. The authors studied 77 adult patients with various arthropathies for evidence of parvovirus B19; prevalence of B19 IgG antibody in these patients (63%) was within the same range as that in the general population. Those with a suspicion of viral arthritis had an increased seroprevalence of anti-B19 IgM and B19 genome.
8. Wagner AD, Goronzy JJ, Matteson EL, Weyand CM: Systemic monocyte and T-cell activation in a patient with human parvovirus B19 infection. Mayo Clin Proc 1995, 70:261-265.
9. Poblotzki A, Gigler A, Lang B, Wolf H, Modrow S: Antibodies to parvovirus B19 NS-1 protein in infected individuals. J Gen Virol 1995, 76:519-527. The authors describe an ELISA to detect antibodies to NS-1 in patients with parvovirus B19 that was not previously characterized. These antibodies were detected by western blot analysis and ELISA in the sera of patients with severe parvovirus B19-associated arthritis but not in those with acute or past infection without complications.
10. Rivier G, Gerster JC, Terrier P, Cheseaux J-J: Parvovirus B19 associated monoarthritis in a 5 year old boy. J Rheumatol 1995, 22:766-767.
11. Nikkari S, Roivainen A, Hannonen P, Möttönen T, Luukkainen R, Yli-Jama T, Toivanen P: Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann Rheum Dis 1995, 54:597-600. The authors used PCR to detect the persistence of parvovirus B19 genome in the synovial fluid cells or peripheral blood mononuclear cells from 61 patients with early rheumatoid arthritis and 28 patients with advanced rheumatoid arthritis. Only two cases of parvovirus B19 infection associated with early seropositive arthritis fulfilling the criteria for rheumatoid arthritis were detected. One patient had erosive arthritis, and the other had self-limiting arthritis; both were HLA-DR4 positive.
12. Sasaki T, Murai C, Muryoi T, Takahashi Y, Munakata Y, Sugamura K, Abe K: Persistent infection of human parvovirus B19 in a normal subject [letter]. Lancet 1995, 346:851.
13. Kerr JR, Cartron JP, Curran MD, Moore JE, Elliott M, Mollan RAB: A study of the role of pravovirus B19 in rheumatoid arthritis. Br J Rheumatol 1995, 34:809-813. The authors studied the etiologic role of parvovirus B19 in rheumatoid arthritis. Twenty-one of 26 patients with rheumatoid arthritis and 20 of 26 patients with osteoarthritis had serologic evidence of previous parvovirus B19 infection (anti-B19 IgG); all were negative for serum B19 DNA. However, B19 was demonstrated in the synovium of 10 of 26 rheumatoid arthritis patients and in nine of 26 osteoarthritis patients.
14. Ilaria Jr RL, Komaroff AL, Fagioli LR, Moloney WC, True CA, Naides SJ: Absence of parvovirus B19 infection In chronic fatigue syndrome. Arthritis Rheum 1995, 38:638-641.
15. Godeau B, Palazzo E, Morinet F, Deplanche M, Deforge L, Schaeffer A, Kahn MF: Is Still's disease associated with parvovirus B19 infection? [letter]. Lancet 1994, 345:59-60.
16. Nussinovitch M, Harel L, Varsano I: Arthritis after mumps and measles vaccination. Arch Dis Child 1995, 72:348-349.
17. Schirmer M, Spötl L, Schmutzhard E, Dierich M, Mur E: Acyclovir in acute oligoarticular herpetic arthritis [letter]. Lancet 1995, 346:712-713.